Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI) "ARTEMIDA"

Completed

Phase 3 Results

Main Contacts

Name Phone E-mail
Takeda Study Registration Call Center Contact 800-778-2860 medicalinformation@tpna.com
Trial Manager Clinical Trial Operations Contact +49 (0) 7531-84 clinicaltrials@nycomed.com

Other Locations

Name City State Country Status
Nycomed Investigational Site Grodno Belarus Unknown_status_icon
Nycomed Investigational Site Minsk Belarus Unknown_status_icon
Nycomed Investigational Site Vitebsk Belarus Unknown_status_icon
Nycomed Investigational Site Almaty Kazakhstan Unknown_status_icon
Nycomed Investigational Site Barnaul Russian Federation Unknown_status_icon
Nycomed Investigational Site Ekaterinburg Russian Federation Unknown_status_icon
Nycomed Investigational Site Irkutsk Russian Federation Unknown_status_icon
Nycomed Investigational Site Kazan Russian Federation Unknown_status_icon
Nycomed Investigational Site Krasnoyarsk Russian Federation Unknown_status_icon
Nycomed Investigational Site Moscow Russian Federation Unknown_status_icon
Nycomed Investigational Site Novosibirsk Russian Federation Unknown_status_icon
Nycomed Investigational Site Samara Russian Federation Unknown_status_icon
Nycomed Investigational Site St. Petersburg Russian Federation Unknown_status_icon
Nycomed Investigational Site Tomsk Russian Federation Unknown_status_icon